坦桑尼亚城市地区HBV、HIV及HBV/HIV合并感染者抗病毒治疗3年后的肾脏结局
在坦桑尼亚达累斯萨拉姆纳入499例HBV、HIV或HBV/HIV合并感染者,启动抗病毒治疗并随访3年,用混合效应模型比较eGFR变化。HBV组和HIV组eGFR分别下降4.3和3.7 mL/min/1.73 m2,HBV/HIV组升高5.1 mL/min/1.73 m2;HBV组随访期间eGFR低于HBV/HIV组。
要点
- HBV/HIV合并感染未较单一感染加重肾功能损害。
- HBV组虽较年轻且基线eGFR相似,随访期间eGFR持续较低。
- HBV组和HIV组3年eGFR平均分别下降4.3和3.7 mL/min/1.73 m2。
核心结论
- 在坦桑尼亚队列中,HBV/HIV合并感染与单一感染相比似乎未加重肾功能损害;HBV感染者随访期间eGFR较低,需更长期研究评估eGFR持续变化及感染病程和合并症的影响。
研究设计与样本
- 前瞻性队列研究,纳入坦桑尼亚达累斯萨拉姆499例启动抗病毒治疗的HBV、HIV或HBV/HIV成人感染者,随访3年,采用混合效应模型比较组间及组内eGFR变化。
主要发现
- 分析共纳入499例(HBV 164例、HIV 271例、HBV/HIV 64例),基线平均eGFR分别为106.88、106.03和107.18 mL/min/1.73 m2。
- 从基线至第3年,HBV组平均eGFR下降4.3 mL/min/1.73 m2(95% CI -9.3至0.7),HIV组下降3.7 mL/min/1.73 m2(95% CI -7.8至0.5),HBV/HIV组升高5.1 mL/min/1.73 m2(95% CI -4.7至14.9)。
- 多变量模型中,HBV感染者eGFR低于HIV或HBV/HIV感染者;调整HBV DNA水平和HBeAg状态后,HBV感染者所有随访访视的eGFR均显著低于HBV/HIV感染者。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出需更长期研究评估eGFR的持续变化以及感染病程和其他合并症的贡献。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An enhanced understanding of renal outcomes in persons with chronic HBV, HIV, and HBV/HIV coinfection is needed to mitigate chronic kidney disease in regions where HBV and HIV are endemic. OBJECTIVES: To investigate changes in estimated glomerular filtration rate (eGFR) in adults with HBV, HIV or HBV/HIV enrolled in a 3 year prospective cohort study of liver outcomes in Dar es Salaam, Tanzania and initiated on antiviral therapy. METHODS: We compared eGFR between and within groups over time using mixed-effects models. RESULTS: Four hundred and ninety-nine participants were included in the analysis (HBV: 164; HIV: 271; HBV/HIV: 64). Mean baseline eGFRs were 106.88, 106.03 and 107.18 mL/min/1.73 m2, respectively. From baseline to Year 3, mean eGFR declined by 4.3 mL/min/1.73 m2 (95% CI -9.3 to 0.7) and 3.7 (-7.8 to 0.5) in participants with HBV and HIV, respectively, and increased by 5.1 (-4.7 to 14.9) in those with HBV/HIV. In multivariable models, participants with HBV had lower eGFRs compared with those with HIV or HBV/HIV and, after adjusting for HBV DNA level and hepatitis B e antigen (HBeAg) status, significantly lower eGFRs than those with HBV/HIV at all follow-up visits. CONCLUSIONS: In this Tanzanian cohort, coinfection with HBV/HIV did not appear to exacerbate renal dysfunction compared with those with either infection alone. Although overall changes in eGFR were small, persons with HBV experienced lower eGFRs throughout follow-up despite their younger age and similar baseline values. Longer-term studies are needed to evaluate continuing changes in eGFR and contributions from infection duration and other comorbidities.
引用
- Wu EL, Christian B, Rivera AS, et al. Renal outcomes in adults with HBV, HIV and HBV/HIV coinfection after 3 years of antiviral therapy in urban Tanzania. J Antimicrob Chemother. 2024. PMID: 37935111. doi:10.1093/jac/dkad341
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。